Field Status Review — BPO Queue
Review the ingestion and validation status of each field that needs judgement. Confirm or correct AI-prepared values, resolve policy and clearance exceptions, and approve a complete submission for underwriting. Nothing is written to AQUA before approval.
AI assessment for underwriter review — advisory only. It contains no pricing: any premium shown anywhere on this page is a figure the broker submitted, not one the AI produced. Generated Oct 2, 2026 2:11 PM using gpt-5.6-luna.
Operations
StateServ Parent, LLC is presented as a multi-state pharmacy and durable medical equipment provider serving hospice, chronically ill Medicare and Medicaid patients, and post-acute-care organizations. Operations include mail-order and courier medication distribution, non-sterile compounding, low-risk sterile compounding, DME and oxygen-related services, pharmacy support, and technology-enabled care-at-home services. The submission identifies 188 full-time and 9 part-time pharmacists, 242 full-time and 5 part-time pharmacy technicians, plus 430 full-time and 14 part-time employees in the broader schedule. Only the Mesa, Arizona address is scheduled, although operations are described in Pennsylvania, Ohio, Maryland, New York, Oregon, and Tennessee.
Risk narrative
Current posture is decline under the applied Dellwood rule, with a possible re-underwriting path only if the class and insured structure change. This is a high-severity pharmacy/DME account: non-sterile and low-risk sterile compounding, medication distribution to hospice and chronically ill patients, DME/oxygen, and clinical or technology support create products, professional, vulnerable-person, and delivery exposures. The schedule shows only one Mesa address although operations span six states, so location and aggregation are unknown. Revenue is inconsistent—$420,000,000 for rating versus $870,000,000 total revenue in the application—and the parent/operating-entity relationship is unresolved. No current loss runs are supplied. The requested $5,000,000 excess layer cannot be evaluated because carrier, underlying limits, and attachment information conflict. No verified premises incident was supplied; BestPlaces scores are advisory ZIP context only.
Hazards severity and frequency graded separately — they drive different decisions
A dispensing or compounding error can cause severe injury to vulnerable patients and can generate widespread products/completed-operations aggregation.
Controls noted: The application identifies licensed pharmacy operations, pharmacist and technician staffing, recent accreditations or surveys, and stated operation primarily through hospice and post-acute channels.
Control gaps: No detailed compounding protocols, quality-assurance program, error and adverse-event reporting, recall procedures, batch controls, inspection findings, corrective-action plans, or product-liability loss information was provided.
Equipment failure, incorrect setup, oxygen-related events, or delivery errors may produce serious injury or property damage away from the scheduled premises.
Controls noted: The submission evidences DME and pharmacy operations, courier and FedEx distribution, and a post-acute-care service model.
Control gaps: The file does not establish the equipment categories actually sold or serviced, installation and repair practices, customer training documentation, rental-agreement controls, service-facility authorization, contractor controls, delivery responsibilities, or owned-vehicle exposure.
Professional judgment errors may create severe individual losses and may fall outside or conflict with a GL-only structure.
Controls noted: The operation uses pharmacists and serves institutional and post-acute-care clients; the ISO profile contemplates limited pharmacist professional-services coverage.
Control gaps: The scope of pharmacist consultation, medication-management activities, remote monitoring, clinical support, professional-liability coverage, and applicable exclusions or endorsements is not established.
Entity or program gaps could leave operating activities uninsured and make loss aggregation, prior acts, and attachment analysis unreliable.
Controls noted: The application identifies a 2023 acquisition and current management; the submission provides a named parent entity and a stated six-state operating footprint.
Control gaps: The operating subsidiaries, provider-contract entities, employees, inventory owners, locations, vehicles, and additional insured structure are not fully scheduled. Legacy and acquired-operations liability has not been reconciled to the named insured.
Premises exposure cannot be rated or evaluated reliably while the only scheduled location may not represent the actual operating footprint.
Controls noted: The Mesa address is scheduled and publicly associated with the StateServ/Dragonfly organization.
Control gaps: Occupancy, square footage, public access, stored equipment or medication, visitor volume, building controls, and whether fulfillment occurs at the suite are not provided. The supplied public profile describes a corporate or technology setting rather than a confirmed retail or fulfillment premises.
Overall grade 4/5. The account has elevated severity potential from compounding, medication products, DME/oxygen, professional support, and vulnerable hospice or chronically ill patients, although the supplied facts do not establish high-risk sterile compounding or a catastrophe-scale manufacturing operation.
Catastrophe exposure
The scheduled Mesa, Arizona location has the ordinary regional exposure of a Southwest commercial premises. Supplied property context reports flood-zone designations of C and X described as minimal flood hazard, but no formal flood determination was reviewed. The six-state operating footprint is not scheduled, so catastrophe aggregation and location-specific natural-hazard exposure remain unknown.
Loss analysis Insufficient data0 yr(s) supplied
No carrier loss runs were provided; the application reports no claims, but the loss picture is unestablished and cannot be experience-rated.
- High No five-year carrier loss runs or policy-period table was supplied, so frequency, severity, reserve development, and trend cannot be evaluated.
Appetite view Decline
The guideline result is OutOfAppetite and the Dellwood class guidance expressly marks Premises/Operations, Products/Completed Operations, and Package authority as Prohibited for class 45900. My view is also Decline as submitted because the operation is broader than the submitted mail-order class and the entity, exposure, location, loss, and excess-tower information is incomplete. If the class is changed to an eligible class, the account should be resubmitted rather than silently reclassified.
In favour
- The application states no Professional, General Liability, Employee Benefits, or Umbrella claims or suits in the past five years, subject to verification by loss runs.
- The organization reports approximately 22 years in business and current management since opening.
- The submission identifies pharmacist and technician staffing, pharmacy licensing, and recent accreditation or survey activity.
- The financial statements were audited by PricewaterhouseCoopers LLP for Dragonfly Health, Inc. and subsidiaries.
- The exposure is commercially significant and could support account-rounding opportunities if the legal entities, operations, and appetite are resolved.
Concerns
- Class 45900 has Premises/Operations authority of P.
- Class 45900 has Products/Completed Operations authority of P.
- Class 45900 has Package authority of P.
- The guideline identifies compounding, professional, and delivery as relevant hazards and assigns maximum capacity of M.
- The portfolio guidance states that the typical account has annual revenues under $250,000,000, while the submitted revenue is at least $420,000,000 and may be $870,000,000 depending on scope.
- All scheduled underlying carriers must meet the supplied AM Best A- VI or better requirement, which has not been confirmed.
Business opportunity Win likelihood Low
The broker disclosed incumbent Hanover primary and excess coverage and is seeking an additional layer on an urgent October 1 effective date, suggesting a capacity or tower-placement problem rather than a clean marketing opportunity. Win probability is reduced by the current class prohibition, carrier conflicts, incomplete schedule, and absence of loss runs.
Why it is in the market. The file appears to be seeking additional excess capacity over an incumbent Hanover program, with an urgent October 1 effective date. The urgency and conflicting carrier documents are a placement concern rather than a positive indication of a well-organized opportunity.
The account is large and potentially valuable to a brokerage casualty book, but the current class is prohibited, the risk exceeds the typical revenue profile in the supplied guidance, and the submission is not decision-ready. Maintain clearance only for a clarified, eligible resubmission.
Account rounding leads
- Property. Pharmacy, DME, oxygen, inventory, equipment, and multiple operating locations imply property exposure, but no complete location or inventory schedule is supplied.
- Workers Compensation. The submission identifies 430 full-time and 14 part-time employees, including pharmacists and pharmacy technicians.
- Commercial Auto. Medication and DME are distributed by courier and FedEx; owned or hired vehicle exposure is not established and should be evaluated.
- Professional Liability. Pharmacist support, consultations, medication-related services, and post-acute-care patients create professional-services exposure beyond ordinary GL.
- Cyber. The organization uses technology platforms, EMR integration, digital tools, and patient or provider information in its care-at-home model.
- EPLI. The account has a substantial multi-state workforce and a complex acquired-entity structure.
- Umbrella or Excess. The broker is specifically seeking an additional $5,000,000 excess occurrence layer, but the existing $10,000,000 Hanover proposal and requested attachment need reconciliation.
Questions for the broker
- High Is StateServ Parent, LLC the entity directly conducting the pharmacy, DME, compounding, delivery, and technology operations, or is it a parent or acquisition entity? Please identify every operating entity to be insured.Entity misalignment can leave the actual operators, employees, inventory, contracts, or prior acts outside the policy.
- High Please provide a complete location schedule for all operating states and allocate annual gross sales, prescriptions, employees, DME activity, compounding, and fulfillment by location and legal entity.The current one-location schedule does not support premises, aggregation, classification, or catastrophe analysis for the described six-state operation.
- High Please reconcile the $420,000,000 projected pharmacy or rating revenue with the application figures of $420,000,000 pharmacy revenue, $450,000,000 benefit-management revenue, and $870,000,000 total revenue. What exact amount is subject to the GL rating basis?The exposure directly changes the rating, premium, attachment analysis, and appetite assessment.
- High Are the pharmacy operations exclusively mail-order or Internet based, or are there physical retail pharmacies? If physical, do any locations provide table or counter service for food or beverages?The answer determines whether submitted class 45900 applies or whether class 12374 or class 12375 should be considered as an alternative, subject to underwriter approval.
- High What is the final requested excess structure: an additional $5,000,000 occurrence layer, a $5,000,000 attachment over primary, or another position above the referenced $10,000,000 Hanover umbrella? Please provide all underlying limits and carriers.The attachment, underlying limits, aggregates, and carrier quality are required to evaluate severity and excess capacity.
- High Can you provide five years of currently valued loss runs for GL, products, professional, employee benefits, and umbrella, and explain the Dallas County matter naming StateServ Parent, LLC?The no-claims application statement is not sufficient to establish a clean record or assess the public court matter.
- High Please confirm whether ISO GL class 12374 — Drugstores - no table or counter service for beverage or food applies, and provide the annual gross sales required by its authoritative rating basis (Gross Sales).The classification can be reviewed now, but a technical premium cannot be calculated until the underwriter confirms the class and the broker supplies its compatible exposure.
- High Please confirm whether ISO GL class 12375 — Drugstores applies, and provide the annual gross sales required by its authoritative rating basis (Gross Sales).The classification can be reviewed now, but a technical premium cannot be calculated until the underwriter confirms the class and the broker supplies its compatible exposure.
- High Please confirm whether ISO GL class 45900 — Mail Order or Online Drugstores applies, and provide the annual gross sales required by its authoritative rating basis (Gross Sales).The classification can be reviewed now, but a technical premium cannot be calculated until the underwriter confirms the class and the broker supplies its compatible exposure.
- Medium What compounding controls, pharmacy inspection results, corrective-action plans, dispensing-error reporting, recall procedures, and pharmacist professional-services activities apply to each pharmacy?These facts determine severity, products coverage, professional coverage, exclusions, and whether the risk is acceptable.
- Medium Does the insured own or control delivery vehicles, perform DME installation or repair, use subcontractors, provide customer equipment training, or service oxygen and life-support equipment?The answer changes auto, contractor, products, completed-operations, and severity analysis.
Information still needed
- Final legal-entity, ownership, and additional-insured schedule covering StateServ Parent, LLC, Dragonfly Health, Inc., and operating subsidiaries.
- Complete physical location schedule and location-level exposure allocation for all operating states.
- Final ISO GL class and rating basis for pharmacy, physical pharmacy, mail-order, compounding, DME, professional, and technology operations.
- Reconciliation of $420,000,000 rating revenue, $420,000,000 pharmacy revenue, and $870,000,000 total revenue.
- Five years of currently valued loss runs and documentation of the Dallas County lawsuit.
- Final underlying declarations, attachment point, limits, aggregates, forms, carriers, and AM Best ratings.
- Compounding, pharmacy quality-control, DME, oxygen, delivery, contractor, and professional-services underwriting details.
- UW confirmation of suggested class 12374 — Drugstores - no table or counter service for beverage or food, plus annual gross sales; premium remains $0 because exposure is unavailable, not because the risk has no premium.
- UW confirmation of suggested class 12375 — Drugstores, plus annual gross sales; premium remains $0 because exposure is unavailable, not because the risk has no premium.
- UW confirmation of suggested class 45900 — Mail Order or Online Drugstores, plus annual gross sales; premium remains $0 because exposure is unavailable, not because the risk has no premium.
What this assessment could not establish. The assessment is based on the supplied submission package, authoritative loss arithmetic, AQUA ISO GL output, Dellwood guidance, and public-research ledger. No independent public research was performed. No carrier loss runs, claim valuations, complete location schedule, final underlying declarations, or complete rating-basis reconciliation were supplied. The public Dallas County record is not treated as an insurance claim, and no public premises incident finding was supplied. BestPlaces scores and other area or property context are advisory only; the supplied unverified property-permit and commercial-property records were not used as incident or eligibility conclusions. The current class may not be the correct class for the full operation.
The email states that primary and excess coverage are with Hanover, while a supplemental application lists Travelers Property & Casualty and an attached proposal identifies Massachusetts Bay Insurance Company as an underlying carrier. The current carrier structure requires confirmation.
Choose and record the value that should control the submission.
The broker submission identifies StateServ Parent, LLC and the website states that StateServ is now Dragonfly Health, while financial statements are titled Dragonfly Health, Inc. and Subsidiaries. The exact legal-entity, DBA, parent, and named-insured relationship is not established.
Use the legal named-insured name shown on the controlling application or approved source.
The broker submission states projected revenue of $420,000,000, while the supplemental application reports $420,000,000 pharmacy revenue, $450,000,000 benefit-management revenue, and $870,000,000 total revenue. The applicable rating revenue and scope must be reconciled.
Use the broker or agency identity confirmed by BPO from the source email and application.
The submission describes operations in Pennsylvania, Ohio, Maryland, New York, Oregon, and Tennessee, but the available schedule provides only the Mesa, Arizona address and no complete location-level revenue or class allocation.
Use the verified mailing or principal address selected by BPO, and record the other address as an explanation if needed.
The email requests an additional $5,000,000 excess occurrence layer, while an attached Hanover proposal shows a $10,000,000 umbrella occurrence limit. The requested layer, underlying limits, attachment point, and relationship between the proposal and requested quote require confirmation.
Choose and record the value that should control the submission.
The operation spans physical pharmacies, mail-order pharmacy, compounding, DME, courier delivery, and related technology services. The recommended primary class is Mail Order or Online Drugstores, with Drugstores as an alternative, but no printed ACORD GL class code or Schedule of Hazards was provided.
Choose and record the value that should control the submission.
From:
Michele Vincent <mvincent@dellwood.com>
Date: Tuesday, September 29, 2026 at 8:59 AM
To: Dellwood BPO <dellwoodbpo@newtecinsurance.com>
Subject: StateServ Parent, LLC eff 10/1/2026 URGENT
Resent-From: <ygaton@newtecemail.com>
Please clear for me - urgent – thank you
Michele Vincent
AVP, Allied Medical Healthcare
mvincent@dellwood.com
346-456-6717
www.dellwood.com
Please note our submission inboxes:
LTCsubmissions@dellwood.com Long Term Care
Healthcaresubmissions@dellwood.com Allied, Social & Human Services
Hospitalsubmissions@dellwood.com HPL Excess
From: Carrie Barger <Carrie_Barger@rpsins.com>
Sent: Tuesday, September 29, 2026 10:13 AM
To: Michele Vincent <mvincent@dellwood.com>
Cc: James McNitt <James_McNitt@rpsins.com>; Hannah Wojdyla <Hannah_Wojdyla@rpsins.com>
Subject: New Business Submission: StateServ Parent, LLC eff 10/1/2026
CAUTION: This email originated from outside your organization. Exercise caution when opening attachments or clicking links, especially from unknown senders.
Good morning Michele,
Please see the new business submission for a pharmacy/durable medical equipment provider in multiple states. Please clear for RPS Healthcare
Chicago and James McNitt. You can contact Carrie Barger with any correspondence.
Named Insured:
StateServ Parent, LLC
1201 Alma School Road, Suite 4000
Mesa, Arizona 85210
Effective Date: 10/1/2026
Lines/Limits Requested:
Excess - $5M occurrence
Website:
https://www.stateserv.com/
StateServ Parent, LLC is a provider of durable medical equipment (DME) solutions focused on supporting post-acute care organizations through
timely service, streamlined equipment management, and technology-driven resources. The pharmacies primarily serve hospice patients, while the New York pharmacy also provides services to chronically ill Medicare and Medicaid patients. The pharmacies are licensed
in multiple states, with the exception of the Bend, Oregon location. Medications are distributed via courier services and mail order, including FedEx. StateServ Parent, LLC operates in Pennsylvania, Ohio, Maryland, New York, Oregon, and Tennessee. The insured
currently maintains both its primary and excess coverage with Hanover. The primary premium is $696,564, and the excess premium is $312,726.
Exposures:
Projected Revenues: $420,000,000
Number of Prescriptions:
- Non-Sterile Compounding (Simple): 62,112
- Non-Sterile Compounding (Moderate): 18,472
- Sterile Compounding Prescriptions (Low Risk): 1,350
Staff:
- FT Pharmacist: 188
- PT Pharmacist: 9
- FT Pharmacy Technician: 242
- PT Pharmacy Technician: 5
Attached you will find completed applications and financials.
Please review and let us know what else you may need to quote the additional $5M excess over the current program.
Thank you,
|
Carrie Barger |
|
The information contained in this email (and any attachments hereto) may be confidential. It has been sent for the sole use of the intended recipient(s). If the reader of this message is not an intended recipient,
you are hereby notified that any unauthorized review, use, disclosure, dissemination, distribution, or copying of this communication, or any of its contents (and any attachments hereto), is strictly prohibited. If you have received this communication in error,
please immediately notify the sender and permanently and securely delete/destroy the original and all copies or printouts of the message (and any attachments hereto).
- Appetite No class is confirmed yet, so appetite cannot be checked.
- SIC / NAICS Neither an SIC nor a NAICS code was stated in the submission.
Required fields complete · critical fields reviewed · conflicts resolved or waived · routing confirmed.
Use this only when a rule or underwriting decision means the submission should not proceed. It will be sent to GYEArchives@onesysins.com and recorded in the audit trail.
Suggested reason — AI and clearance rules prepared this wording for you. Review and edit it before sending.
Approval is currently unavailable: This submission is already in IN UNDERWRITING.